Showing results (271-280 of 331) with videos related to

Sort By:
Pageof 34
International Angiology : a Journal of the International Union of Angiology|July 25, 2000
Pharmacokinetics of argatroban in primates: evidence on endogenous uptakeS Ahmad, L H Yang, A Ahsan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 30, 1998
Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27W R Lee, B Berkey, V Marcial, et al.
International Journal of Radiation Oncology, Biology, Physics|August 25, 2007
Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03)Mitchell Machtay, Thomas F Pajak, Mohan Suntharalingam, et al.
PNAS Nexus|July 31, 2024
Resonance sonomanometry for noninvasive, continuous monitoring of blood pressureRaymond Jimenez, Dominic Yurk, Steven Dell, et al.
The Journal of Clinical Investigation|February 1, 1992
Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptorY K Fu, S Arkins, G Fuh, et al.
Acta Neurologica Scandinavica|November 22, 2007
Lower dopamine transporter density in an asymptomatic patient with Kleine-Levin syndromeM Q Hoexter, M C Shih, D D Mendes, et al.
Molecular and Cellular Neurosciences|November 21, 2000
Cloning and characterization of muscle-specific kinase in chickenF C Ip, D G Glass, D R Gies, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1997
Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinomaQ T Le, K K Fu, S Kroll, et al.
International Journal of Radiation Oncology, Biology, Physics|October 8, 2003
P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003E Hammond, Brian A Berkey, Karen K Fu, et al.
Blood|July 27, 2001
HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cellsC Nicot, J C Mulloy, M G Ferrari, et al.
Pageof 34